Français
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
coccidioidomycosis/fièvre
Le lien est enregistré dans le presse-papiers
10 résultats
Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
This study is being conducted to collect safety and immunogenicity data for the RVF vaccine, TSI-GSD 200, Lot 7, Run 2. Enrollment in this protocol is offered for personnel who enter areas where this virus is used in research or is endemic (an area where this disease process is found to occur
Improving the Appearance of Skin and Hair in Patients Undergoing Valley Fever Treatment
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Coccidioidomycosis, also known as Valley Fever, is a fungal condition most commonly seen in Arizona and can affect multiple organs, including the skin, lung, bone, joints, and central nervous system. Oral antifungal therapy such as fluconazole is the first-line medication to treat
Study in Healthy Volunteers to Evaluate the Safety and Immunogenicity of AGS-v, a Universal Mosquito-Borne Disease Vaccine
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Mosquito-borne diseases continue to cause significant morbidity and mortality worldwide despite on-going control efforts. In 2015, there were >200 million cases of malaria worldwide, causing nearly half a million deaths, with most of the deaths occurring among children under the age of 5 years.
Efficacy Study of Fluconazole to Treat Coccidioidomycosis Pneumonia (Valley Fever)
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
This is a Phase IV randomized, double-blinded, placebo-controlled study in 1000 individuals, aged 18 years or older, with community acquired pneumonia (CAP) who meet all eligibility criteria in endemic regions. This study is designed to provide data on the effectiveness of early antifungal treatment
Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The primary objectives are to assess safety of Rift Valley Fever (RVF) Vaccine, Inactivated (TSI-GSD 200) and to assess immunogenicity of Rift Valley Fever (RVF) Vaccine, Inactivated (TSI-GSD 200). The secondary objective is to assess incidence of RVF infection in vaccinated personnel
Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Retrospective chart review of all patients with an inflammatory arthritis seen at the University Rheumatology clinic since January 2000.
Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Every year there are 50,000 new U.S. cases of coccidioidomycosis (Valley Fever). The majority of these illnesses occur as a result of endemic exposure in Arizona and California. The benefits of antifungal therapy for uncomplicated disease are not currently established. Current therapies for serious
Safety and Immunogenicity Study of Rift Valley Fever Vaccine
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Study Objectives:
The objectives of this two-part, primary immunization and booster dose, study are to continue to collect safety data on Rift Valley Fever (RVF) Vaccine, Inactivated (TSI-GSD 200); and, to continue to collect immunogenicity data on Rift Valley Fever (RVF) Vaccine, Inactivated
Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Rift Valley Fever (RVF) is a mosquito-borne disease in Africa that affects both humans and animals. The disease poses a significant endemic disease threat, and the etiologic agent (RVF virus) possesses physical and biochemical characteristics that have resulted in its classification as a Category A
Rift Valley Fever in Kenya
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The objective of this research is to better define the extent and timing of Rift Valley Fever (RVF) virus transmission and its related chronic disease/infection attack rate, during an interepidemic period in a high-risk region that has seen repeated RVF outbreaks. The results will be used to develop
La base de données d'herbes médicinales la plus complète soutenue par la science
- Fonctionne en 55 langues
- Cures à base de plantes soutenues par la science
- Reconnaissance des herbes par image
- Carte GPS interactive - étiquetez les herbes sur place (à venir)
- Lisez les publications scientifiques liées à votre recherche
- Rechercher les herbes médicinales par leurs effets
- Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets
Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées
